RESEARCHER PROFILE

Tamer M. Ibrahim

← Back to Kafrelsheikh University

T

Kafrelsheikh University

Synthesis and Characterization of Heterocyclic CompoundsSynthesis and biological activityComputational Drug Discovery MethodsResearch on Leishmaniasis StudiesSARS-CoV-2 and COVID-19 Research

Tamer M. Ibrahim works in Synthesis and Characterization of Heterocyclic Compounds, Synthesis and biological activity, Computational Drug Discovery Methods, Research on Leishmaniasis Studies, SARS-CoV-2 and COVID-19 Research. Recorded institutional associations include Kafrelsheikh University, British University in Egypt, University of Freiburg.

74Publications
1,903Citations
28H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 – A Public Library of Challenging Docking Benchmark Sets

    2013 · 200 citations
  2. Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative

    2021 · 105 citations
  3. Leishmania treatment and prevention: Natural and synthesized drugs

    2018 · 98 citations
  4. Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

    2009 · 95 citations
  5. 1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities

    2023 · 74 citations
  6. Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents

    2018 · 68 citations
  7. In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches

    2021 · 66 citations
  8. Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors

    2021 · 64 citations
  9. Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles

    2018 · 56 citations
  10. Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones

    2019 · 53 citations
  11. Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties

    2023 · 50 citations
  12. Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents

    2019 · 44 citations
  13. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives

    2018 · 43 citations
  14. Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition

    2019 · 43 citations
  15. Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization

    2015 · 40 citations
  16. Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking

    2020 · 40 citations
  17. New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies

    2022 · 40 citations
  18. Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation

    2023 · 38 citations
  19. Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors

    2020 · 36 citations
  20. Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer

    2023 · 36 citations
  21. Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer

    2022 · 35 citations
  22. Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors

    2021 · 34 citations
  23. Synthesis, Molecular Modeling and Biological Screening of Some Pyrazole Derivatives as Antileishmanial Agents

    2018 · 33 citations
  24. Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors

    2020 · 33 citations
  25. Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents

    2018 · 31 citations

← Return to the university profile